Digital Glucose Monitoring in Gestational Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02783612|
Recruitment Status : Recruiting
First Posted : May 26, 2016
Last Update Posted : May 26, 2016
Assessing blood glucose control in women with gestational diabetes can be challenging. The standard of care remains visual inspection of blood glucose paper diaries of self-performed capillary monitoring during regular meeting in High Risk pregnancy clinics.
The researchers are interested in preforming a randomized control trial comparing women with the diagnosis of gestational diabetes with regular High-Risk clinic surveillance to digital monitoring using an application in a Smart-phone and submitting those values via email in addition to the regular clinic appointments.
The Primary outcome of the trial is to assess the compliance of the research group as compared to the control group.
|Condition or disease||Intervention/treatment||Phase|
|Gestational Diabetes||Other: glucose buddy application||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Improvement of Compliance by Digital Blood Glucose Monitoring of Women With Gestational Diabetes|
|Study Start Date :||March 2016|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||July 2018|
Experimental: glucose application
Regular high risk pregnancy clinic surveillance in addition to a Smart phone application for registering the Blood glucose levels and submitting via email every 3-5 days to the High risk Doctor involved in the trial.
Other: glucose buddy application
No Intervention: Regular monitoring
Regular high risk pregnancy clinic surveillance
- Assessing the compliance of the research group compared to the control group. [ Time Frame: 18 month ]By calculating the amount of daily glucose measurements in the research group compared to the number of glucose measurements in the control group
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02783612
|Contact: Hadas Miremberg, MDfirstname.lastname@example.org|
|Wolfson medical center||Recruiting|
|Contact: Hadas Miremberg, MD 972526741740 email@example.com|